Use Of Deoxyribonuclease I In The Treatment Of Endometriosis In

Use Of Deoxyribonuclease I In The Treatment Of Endometriosis In Patients With An Epigenetic Signature Of Endometriosis On Cell Free Dna

Abstract: The invention relates to a method for treating endometriosis, by administering DNase I, and, in particular, for treating a patient with a cell-free DNA level above normal, a fortiori if this cell-free DNA has a methylation profile typical of endometriosis.

Patent Information

Application #

Filing Date

04 August 2023

Publication Number

49/2023

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

ENDOLIFE

43 rue de Courcelles 75008 PARIS

Inventors

1. HAZOUT, André

9 rue Beethoven 75016 PARIS

2. BEN KHALIFA, Moncef

8 place des Pensées 78320 LE MESNIL-SAINT-DENIS

Specification

Documents

Application Documents

#	Name	Date
1	202317052499-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [04-08-2023(online)].pdf	2023-08-04
2	202317052499-STATEMENT OF UNDERTAKING (FORM 3) [04-08-2023(online)].pdf	2023-08-04
3	202317052499-Sequence Listing in txt [04-08-2023(online)].txt	2023-08-04
4	202317052499-Sequence Listing in PDF [04-08-2023(online)].pdf	2023-08-04
5	202317052499-PRIORITY DOCUMENTS [04-08-2023(online)].pdf	2023-08-04
6	202317052499-FORM 1 [04-08-2023(online)].pdf	2023-08-04
7	202317052499-DECLARATION OF INVENTORSHIP (FORM 5) [04-08-2023(online)].pdf	2023-08-04
8	202317052499-COMPLETE SPECIFICATION [04-08-2023(online)].pdf	2023-08-04
9	202317052499-Proof of Right [03-11-2023(online)].pdf	2023-11-03
10	202317052499-FORM-26 [03-11-2023(online)].pdf	2023-11-03
11	202317052499-FORM 3 [03-11-2023(online)].pdf	2023-11-03
12	202317052499-Form-4 u-r 138 [24-02-2025(online)].pdf	2025-02-24
13	202317052499-FORM 18 [27-02-2025(online)].pdf	2025-02-27